Press Releases

Date Title and Summary Additional Formats
Toggle Summary Amphastar Pharmaceuticals Announces Pricing of Initial Public Offering
RANCHO CUCAMONGA, Calif., June 25, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Amphastar) (Nasdaq:AMPH), a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable and
View HTML
Toggle Summary Amphastar Pharmaceuticals Announces Exercise of Over-Allotment Option
RANCHO CUCAMONGA, Calif. , June 30, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Amphastar) (Nasdaq:AMPH), a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable and
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 12, 2014
RANCHO CUCAMONGA, Calif., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its second quarter of 2014 ended June 30, 2014, after the market closes on Tuesday, August 12, 2014, and will hold a conference call to
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Revenues of $49.0 Million for the Second Quarter Ended June 30, 2014
RANCHO CUCAMONGA, Calif., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") today reported results for the second quarter ended June 30, 2014. Net revenues of $49.0 million for the second quarter GAAP net loss of $1.2 million or $0.03 per
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 12, 2014
RANCHO CUCAMONGA, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its third quarter of 2014 ended September 30, 2014, after the market closes on Wednesday, November 12, 2014, and will hold a conference call
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Revenues of $59.7 Million for the Third Quarter Ended September 30, 2014
RANCHO CUCAMONGA, Calif., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") today reported results for the third quarter ended September 30, 2014. Net revenues of $59.7 million for the third quarter GAAP net loss of $5.4 million or $0.12
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 24, 2015
RANCHO CUCAMONGA, Calif., March 17, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its fourth quarter of 2014 ended December 31, 2014, after the market closes on Tuesday, March 24, 2015, and will hold a conference call to
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Revenues of $55.9 Million for the Fourth Quarter Ended December 31, 2014
RANCHO CUCAMONGA, Calif., March 24, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") today reported results for the fourth quarter ended December 31, 2014. Net revenues of $55.9 million for the fourth quarter GAAP net loss of $2.5 million, or
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference
RANCHO CUCAMONGA, Calif., April 14, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced today that Jason Shandell, President will be presenting at the 14 th Annual Needham Healthcare Conference on Wednesday, April 15, 2015 at 12:10 p.m.
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 13, 2015
RANCHO CUCAMONGA, Calif. , May 7, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its first quarter of 2015 ended March 31, 2015 , after the market closes on Wednesday, May 13, 2015 , and will hold a conference call to
View HTML

 

Copyright ©2018 Amphastar Pharmaceuticals, Inc.

Privacy      Terms & Conditions

This site is intended for residents of the United States